Clinical Trial Update: Stem Cell Derived Exome for Treatment of Diabetic Foot [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial is planned to evaluate a stem cell-derived exosome therapy for diabetic foot ulcers; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• Stem Cell Derived Exosome Therapy

Snippet

Sponsor: Second Affiliated Hospital of Guangzhou Medical University | Conditions: Diabetic Foot, Stem Cell | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING